Gestational pre-diabete. Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified
Conditions
Interventions
Intervention 1: Intervention group: The intervention group, in addition to receiving the usual care, will have three 90-minute sessions and one day apart education. Intervention 2: Control group: The
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Have informed written consent to participate in the research.2. Gestational age based on LMP or ultrasound of the first half of pregnancy is between 14-10 weeks.3. Have a fasting blood sugar between 125-93.4. The body mass index is less than 30.5. Iranian and resident of Mashhad.6. Have at least fifth grade elementary education.7. Be able to communicate verbally.8. Pregnancy is monogamous9. Do not have cigarette and drug addiction.10. Do not use metformin pills and other blood glucose lowering drugs11. There is no history of medical illness.12. Failure to have a significant incident during the preceding three months13. During the past year, there is no history of referral to a psychiatrist or psychologist, taking medication or hospitalization due to mental illness.14. There is no high risk pregnancy.15. There are no midwifery problems.16. Due to underlying illness, it has not been used consistently with glucocorticoid drugs17. Phone number to call.
Exclusion criteria
Exclusion criteria: 1. Unwillingness to continue to attend research2. Fasting blood glucose more than 93 and blood sugar two hours later food more than 120, two weeks after intervention3. Major stressful incidents during research4. Not attending any of the training sessions5. Participate in classes with similar content6. Occurrence of pregnancy-related complications7. During the study, the child was born or aborted.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-care. Timepoint: Before the intervention, 2 weeks after the intervention and 24-28 weeks of pregnancy. Method of measurement: Self-care questionnaire.;Self-efficacy. Timepoint: Before the intervention, 2 weeks after the intervention and 24-28 weeks of pregnancy. Method of measurement: Self-efficacy questionnaire.;Blood sugar. Timepoint: Before the intervention, 24-28 weeks of pregnancy. Method of measurement: Glucose test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Eshghi Motlagh
Mashhad University of Medical Sciences
Outcome results
None listed